Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1749 (LINC01749)
- Target
- LINC01749
- Molecular classification
- Long intergenic non-coding RNA, Long non-coding RNA (lncRNA), Non-coding RNA
01
Overview
Long intergenic non-protein coding RNA 1749 (LINC01749) is a member of the lincRNA family, which are long RNAs (>200 nucleotides) transcribed from intergenic regions, not overlapping coding genes. LINC01749, like other lincRNAs, participates in the regulation of gene expression, potentially through chromatin modification, transcriptional control, and enhancer-like activities. Its expression has tissue specificity, and some evidence links it to roles in the progression or prognosis of esophageal squamous cell carcinoma, although its exact molecular functions and disease mechanisms remain largely uncharacterized. LINC01749 is not currently considered a therapeutic target but may be a candidate or biomarker in future studies related to non-coding RNAs and cancer.
02
Mechanism of action
Not applicable. No drugs target this molecule, so no mechanisms are defined.
03
Biological functions
Regulation of gene expressionChromatin remodelingGenome architecture modulationTranscription regulationPossible enhancer-associated activity
04
Disease associations
Cancer (reported association with esophageal squamous cell carcinoma; limited context found)Other (some lincRNAs also have roles in epigenetics and cell development, but specific LINC01749 context is sparse)
05
Biomarkers
Possible biomarker role in esophageal squamous cell carcinoma prognosis models
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1749 (LINC01749).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1749 (LINC01749).